Skip to main content
Clinical Trials/CTRI/2020/11/029053
CTRI/2020/11/029053
Completed
Phase 1

A prospective, multi-centre, non- randomised pilot clinical study to evaluate the safety, feasibility and efficacy of the multi arm robotic system- Mantra in the predetermined surgical procedures (STRS-Soft Tissue Robotic Surgeries) - STRS

Robosurg Med Tech Pvt Ltd SS Innovations Group Company0 sites12 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Robosurg Med Tech Pvt Ltd SS Innovations Group Company
Enrollment
12
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 23, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Robosurg Med Tech Pvt Ltd SS Innovations Group Company

Eligibility Criteria

Inclusion Criteria

  • 1 Male or Female patients with age of eighteen (18\) and above.
  • 2 Able to give written informed consent.
  • 3 Patients meeting the inclusion criteria for one of the following surgical procedures using multi\-arm robotic system for soft tissue surgeries:
  • Cholecystectomy
  • Hysterectomy
  • Nephrectomy
  • Prostatectomy
  • Esophagus mobilization
  • Internal Mammary Artery takedown
  • Lung Lobectomy

Exclusion Criteria

  • ââ?¬Â¢Patients who have participated in another investigational clinical study within thirty (30\) days before screening
  • ââ?¬Â¢Inability to provide informed consent
  • ââ?¬Â¢Uncontrolled hypertension, diabetes mellitus or any other co\-morbidity that is considered as a high risk for the planned surgical procedure
  • ââ?¬Â¢Patients who fall into New York Heart Association (NYHA) Class
  • ââ?¬Â¢History of chronic alcohol or drug abuse.
  • ââ?¬Â¢Chronic renal failure or on dialysis.
  • ââ?¬Â¢Subjects with any other clinically significant unstable medical condition, life\-threatening disease, or anything else in the opinion of the Investigator that would contra\-indicate a surgical procedure.

Outcomes

Primary Outcomes

Not specified

Similar Trials